TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal March 18, 1988